Gallstones

Current Opinion in Gastroenterology

Volumn 16, Issue 5, 2000, Pages 450-453

  Hoogerwerf, Willemijntje A ^a   Soloway, Roger D ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ RECEPTOR; MUCIN;

ARTICLE; BILIARY TRACT SURGERY; GALLSTONE; HUMAN; INSULIN RESISTANCE; PATHOGENESIS; PATHOPHYSIOLOGY; POPULATION RESEARCH; RISK ASSESSMENT;

EID: 0034457231     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-200009000-00011     Document Type: Article

References (20)

1. Prevalence and ethnic differences in gallbladder disease in the United States
2. Association of diabetes, serum insulin, and C-peptide with gallbladder disease
3. Prevalence of cholelithiasis. Results of an epidemiologic investigation in Vidauban, Southeast France
4. Epidemiological study on Korean gallstone disease. A nation wide cooperative study
5. A prospective study of coffee consumption and the risk of symptomatic gallstone disease in men
6. Long-term weight patterns and risk for cholecystectomy in women
7. A recombinant bovine gallbladder mucin polypeptide binds biliary lipids and accelerates cholesterol crystal appearance time
8. No pathophysiologic relationship of soluble biliary proteins to cholesterol crystallization in human bile
9. Apolipoprotein E genotype and the risk of gallbladder disease in pregnancy
10. The role of apolipoprotein E and glucose intolerance in gallstone disease in middle-aged subjects
11. The role of fibrinolytic system proteins in cholesterol gallstone formation
12. Cholic acid aids absorption, biliary secretion, and phase transitions of cholesterol in murine cholelithogenesis
13. Excess membrane cholesterol alters human gallbladder muscle contractility and membrane fluidity
14. CCK receptor dysfunction in muscle membranes from human gallbladders with cholesterol stones
15. ++ secretion by the gallbladder: A risk factor for gallstones
16. Prolonged large bowel transit increases serum deoxycholic acid: A risk factor for octreotide induced gallstones
17. Enterohepatic cycling of bilirubin: A putative mechanism for pigment gallstone formation in ileal Crohn's disease
18. The pravastatin-induced decrease of biliary cholesterol secretion is not directly related to an inhibition of cholesterol synthesis in humans
19. Microstructural evolution of lipid aggregates in nucleating model and human biles visualized by cryogenic transmission electron microscopy
20. Long-term ursodeoxycholic acid therapy is associated with reduced risk of biliary pain and acute cholecystitis in patients with gallbladder stones: A cohort analysis